These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 14222129)

  • 1. [PHARMACOKINETICS AND CLINICO-THERAPEUTIC EFFECTIVENESS OF 4-SULFANILAMIDO-5,6-DIMETHOXYPYRIMIDINE].
    HITZENBERGER G
    Wien Klin Wochenschr; 1964 May; 76():330-4. PubMed ID: 14222129
    [No Abstract]   [Full Text] [Related]  

  • 2. [ON THE PHARMACOKINETICS OF A LONG-ACTING SULFONAMIDE (4-SULFANILAMIDO-5,6-DIMETHOXYPYRIMIDINE) IN NORMAL PERSONS].
    PORTWICH F; BUETTNER H
    Klin Wochenschr; 1964 Aug; 42():740-4. PubMed ID: 14296354
    [No Abstract]   [Full Text] [Related]  

  • 3. CLINICAL PHARMACOLOGY OF 2-SULFANILAMIDO-3-METHOXYPYRAZINE.
    HERTING RL; LOPEZ F; SCHERFLING E; SYLVESTER JC; WIEGAND R
    Antimicrob Agents Chemother (Bethesda); 1964; 10():554-61. PubMed ID: 14287992
    [No Abstract]   [Full Text] [Related]  

  • 4. [PHARMACOKINETICS OF 2-SULFANILAMIDO-5-ETHYLPYRIMIDINE IN MAN].
    PLANCHER AC; SALVI G; BACUZZI E
    Farmaco Prat; 1964 Nov; 19():550-9. PubMed ID: 14234089
    [No Abstract]   [Full Text] [Related]  

  • 5. CHEMICAL PHARMACOLOGY OF 2-SULFANILAMIDO-3-METHOXYPYRAZINE.
    WIEGAND RG; CHUN AH; SCHERFLING E; LOPEZ F; HERTING RL
    Antimicrob Agents Chemother (Bethesda); 1964; 10():549-53. PubMed ID: 14287991
    [No Abstract]   [Full Text] [Related]  

  • 6. [Antibacterial effectiveness of 2-sulfanilamido-5-methoxy-pyrimidine].
    KNOTT T; KUTZSCHE A; WALTER AM
    Arzneimittelforschung; 1961 Aug; 11():684-94. PubMed ID: 14457340
    [No Abstract]   [Full Text] [Related]  

  • 7. Pharmacology of 4-azophenyl-sulfanilamido-o-butylphenol.
    SAZONOVA NA
    Farmakol Toksikol; 1945; 8(2):49. PubMed ID: 21000679
    [No Abstract]   [Full Text] [Related]  

  • 8. [DIAGNOSTIC REACTIVATION OF CHRONIC SINUSITIS].
    SABUGUEIRO M; NEGRI RL; GORRINI V
    Prensa Med Argent; 1964 Sep; 51():669-73. PubMed ID: 14229037
    [No Abstract]   [Full Text] [Related]  

  • 9. [PARADOXES AND EXAMPLES IN THE THERAPY OF INFECTIONS].
    BERGFORS PG
    Sven Lakartidn; 1964 Apr; 61():1378-84. PubMed ID: 14148475
    [No Abstract]   [Full Text] [Related]  

  • 10. CLINICAL TRIAL OF FRUSEMIDE.
    VEREL D
    Lancet; 1965 Jan; 1(7375):49. PubMed ID: 14246690
    [No Abstract]   [Full Text] [Related]  

  • 11. SCREENING OF DRUGS FOR TRIAL IN HUMAN LEPROSY.
    MAYER RL
    Bibl Tuberc; 1964; 19():219-324. PubMed ID: 14271076
    [No Abstract]   [Full Text] [Related]  

  • 12. [TREATMENT OF SOUTH AMERICAN BLASTOMYCOSIS WITH A NEW SULFONAMIDE OF SLOW URINARY ELIMINATION AND WEEKLY ADMINISTRATION].
    HUTZLER RU; AMATONETO V; NETTO CF; LEAO VS
    Hospital (Rio J); 1964 Jul; 66():91-7. PubMed ID: 14181578
    [No Abstract]   [Full Text] [Related]  

  • 13. [PROBLEMS INHERENT IN DRUG THERAPY AND POSOLOGY OF THE NEWBORN].
    VON HARNACKG
    Minerva Pediatr; 1964 Sep; 16():SUPPL:1039-45. PubMed ID: 14204439
    [No Abstract]   [Full Text] [Related]  

  • 14. [S-Sulfanilamido- and 3-sulfanilamido-1,2,4-thiadiazole].
    WOERFFEL U; BEHNISCH R
    Arch Pharm Ber Dtsch Pharm Ges; 1962 Nov; 295/67():811-6. PubMed ID: 14001457
    [No Abstract]   [Full Text] [Related]  

  • 15. [STUDY OF THE ACTIVITY IN VITRO ON NEISSERIA INTRACELLULARIS AND IN VIVO IN CEREBROSPINAL MENINGITIS OF SULFANILAMIDO-4-DIMETHOXY-5,6-PYRIMIDINE].
    FAUCON R; BORIES S; AUDIFFREN P; DIGOUTTE JP; BIDEAU J; BARBOTIN M; LUONG NT; COURTOIS D; WRIGHT J; BONZOM A
    Med Trop (Mars); 1964; 24():SUPPL 1:1-61. PubMed ID: 14234943
    [No Abstract]   [Full Text] [Related]  

  • 16. Some pharmacological aspects of the sulphonamides, penicillin and streptomycin.
    SAPEIKA N
    S Afr Med J; 1946 Nov; 20(22):708-11. PubMed ID: 20278844
    [No Abstract]   [Full Text] [Related]  

  • 17. PHARMACOLOGICAL AND BIOLOGICAL CHARACTERISTICS OF SULFAMETHOXYDIAZINE.
    SENCA H
    West Med Med J West; 1964 Aug; 5():259-61. PubMed ID: 14180036
    [No Abstract]   [Full Text] [Related]  

  • 18. [THE IMPORTANCE OF BINDING TO ALBUMIN, BODY CELLS AND BACTERIA FOR PHARMACODYNAMICS AND EFFECT OF MEDICINAL SUBSTANCES].
    WITZGALL H; BOYENS H
    Arch Int Pharmacodyn Ther; 1964 Apr; 148():511-35. PubMed ID: 14181244
    [No Abstract]   [Full Text] [Related]  

  • 19. [ON PHARMACOKINETICS OF SULFONAMIDES UNDER PATHOLOGICAL CONDITIONS].
    BUETTNER H; PORTWICH F; MANZKE E; STAUDT N
    Klin Wochenschr; 1964 Jan; 42():103-8. PubMed ID: 14128387
    [No Abstract]   [Full Text] [Related]  

  • 20. [Comparative experimental studies on 5-methyl-3-sulfanilamido-isoxazole, other sulfanilamides and antibiotics].
    FUST B; BOEHNI E
    Schweiz Med Wochenschr; 1962 Dec; 92():1599-604. PubMed ID: 13945938
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.